title: Losartan in renal allograft recipients receiving cyclosporine A.
authors.forename: M
authors.initials: M
authors.lastname: Boran
authors.forename: F
authors.initials: F
authors.lastname: Gönen
authors.forename: S
authors.initials: S
authors.lastname: Cetin
mesh_terms: D000328:Adult; D057911:Angiotensin Receptor Antagonists; D016572:Cyclosporine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D004341:Drug Evaluation; D004920:Erythropoiesis / Q000187:drug effects; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D016030:Kidney Transplantation; D019808:Losartan / Q000494:pharmacology*; D008297:Male; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D014527:Uric Acid / Q000097:blood
chemical_list: D057911:Angiotensin Receptor Antagonists; D006454:Hemoglobins; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D014527:Uric Acid; D016572:Cyclosporine; D019808:Losartan